Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|November 3, 2011
Targeting HIV-1 gp41-induced fusion and pathogenesis for anti-viral therapyHimanshu Garg, Mathias Viard, Amy Jacobs, et al.
Biochemistry|February 18, 2004
Solution structure of the coxsackievirus and adenovirus receptor domain 1Shaokai Jiang, Amy Jacobs, Thomas M Laue, et al.
Biochemistry|April 30, 2013
Significant differences in cell-cell fusion and viral entry between strains revealed by scanning mutagenesis of the C-heptad repeat of HIV gp41Barbara Diaz-Aguilar, Karen Dewispelaere, Hyun Ah Yi, et al.
Biochemistry|February 5, 2015
The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutationHyun Ah Yi, Barbara Diaz-Rohrer, Priyanka Saminathan, et al.
Protein Science : a Publication of the Protein Society|May 26, 2007
The disulfide loop of gp41 is critical to the furin recognition site of HIV gp160Jayita Sen, Amy Jacobs, Haiqing Jiang, et al.
Current HIV Research|March 10, 2016
Inhibition of HIV Entry by Targeting the Envelope Transmembrane Subunit gp41Hyun A Yi, Brian C Fochtman, Robert C Rizzo, et al.
Vaccine|February 5, 2008
HIV-1 envelope glycoprotein-mediated fusion and pathogenesis: implications for therapy and vaccine developmentAmy Jacobs, Himanshu Garg, Mathias Viard, et al.
Biochemistry|July 9, 2011
Permanent inhibition of viral entry by covalent entrapment of HIV gp41 on the virus surfaceHyun Ah Yi, Barbara Diaz-Aguilar, Dominique Bridon, et al.
Women'S Health (London, England)|March 21, 2022
"I do the she and her": A qualitative exploration of HIV care providers' considerations of trans women in gender-specific HIV careAshley Lacombe-Duncan, Kathryn R Berringer, Jennifer Green, et al.
Bioorganic & Medicinal Chemistry Letters|May 28, 2015
Small molecule inhibitors of HIVgp41 N-heptad repeat trimer formationWilliam J Allen, Hyun Ah Yi, Miriam Gochin, et al.
Pageof 4